Article
Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine
Rating:
0.0
Views:
62
Likes:
1
Library:
1
Opko Health Inc said on Wednesday it signed a deal with Merck & Co Inc potentially worth up to $922.5 million for its experimental Epstein-Barr virus vaccine.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value